Animalcare Group plc

LSE ANCR.L

Animalcare Group plc EPS (Diluted) for the year ending December 31, 2023: USD 0.03

Animalcare Group plc EPS (Diluted) is USD 0.03 for the year ending December 31, 2023, a -34.86% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Animalcare Group plc EPS (Diluted) for the year ending December 31, 2022 was USD 0.04, a 2,298.40% change year over year.
Animalcare Group plc EPS (Diluted) for the year ending December 31, 2021 was USD -0.00, a -132.21% change year over year.
Animalcare Group plc EPS (Diluted) for the year ending December 31, 2020 was USD 0.01, a 118.49% change year over year.
Animalcare Group plc EPS (Diluted) for the year ending December 31, 2019 was USD -0.03, a -526.88% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

LSE: ANCR.L

Animalcare Group plc

CEO	Ms. Jennifer Ann Julia Winter B.Sc.
IPO Date	Jan. 15, 2008
Location	United Kingdom
Headquarters	Unit 7, York Business Park
Employees	226
Sector	Health Care
Industries Pharmaceuticals Pet Food

Description

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. It is also involved in the wholesale and marketing of veterinary pharmaceuticals. The company serves customers in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc was incorporated in 1972 and is based in York, the United Kingdom.

Key trends

Past 5 years